DaVita: CEO History

DaVita is a Denver-based kidney care provider and a member of the S&P 500. It offers in-center hemodialysis, home peritoneal dialysis and home hemodialysis, hospital inpatient dialysis, and care management for chronic kidney disease. At June 30, 2026 it served about 298,500 patients at 3,266 outpatient centers worldwide. CEO Javier J. Rodriguez has led the company since 2019, and Berkshire Hathaway, its largest shareholder since first buying in 2011, owns about 45%. The company is headquartered in Denver, Colorado.

DaVita is paid per dialysis treatment. Most patients receive in-center hemodialysis about three times a week, while others dialyze at home with DaVita training and support. Medicare's bundled ESRD payment covers the majority of patients, but commercial insurers pay substantially more per treatment, so payer mix is the key profit driver. In Q2 2026 U.S. revenue per treatment was $415.87 against patient care costs of $277.40. Many clinics are joint ventures with nephrology practices, and the Integrated Kidney Care (IKC) unit takes risk-based contracts, including the CMS Kidney Care Choices model, where DaVita shares in savings when total cost of care falls.